David Gilliam
Professor of Psychological Sciences
- B.S.: Emory University, Atlanta, GA
- M.A.: University of Colorado, Boulder, CO
- Ph.D.: University of Colorado, Boulder, CO
Courses Taught:
Psychological Statistics, Research Design and Analysis, Behavioral Genetics, Physiological Psychology
Specialization:
Prenatal Drug Effects
Recent Publications:
- Downing, C., Gaudreau, C., Gilliam, D., & Johnson, T.E. Effects of prenatal alcohol exposure on activity in mice from four inbred strains. Poster presented at the Annual Meeting of the Research Society on Alcoholism, June 23-28, 2006, Baltimore, MD. Published as an abstract in Alcoholism: Clinical and Experimental Research, 30, 232A, 2006.
- Gilliam, D.M. & Smith, S. Preconception and prenatal exposure to ethanol: Effects on fetal facial morphology in mice. A preliminary report. Presented at the 76th Annual Meeting of the Colorado-Wyoming Academy of Science, Mesa State College, Grand Junction, CO, April 2005. Published as an abstract in the Program, Tri-Beta Biological Honor Society and the Journal, Colorado-Wyoming Academy of Sciences, 37, 7, 2005.
- David Gilliam & Katie Roupe, Locomotor response to nicotine in prenatal alcohol exposed CD-1 mice, presented at the Society for Neuroscience, San Diego, CA, October 2004.
- Hart, J. & Gilliam, D. Ethanol Teratogenesis in B6 and D2 Transferred Mouse Embryos. PrNovember 9, 2010Academy of Science, University of Northern Colorado, Greeley, CO, April 2003. Published as an abstract in the Journal, Colorado-Wyoming Academy of Science, 35, 15, 2003.
- Deganhart, N., Hart, J. & Gilliam, D. Limited ethanol teratogenic effects in NSA mice. Presented at the 73rd Annual Meeting Colorado-Wyoming Academy of Science, Mesa State College, Grand Junction, CO, April, 2002. Published as an abstract in the Journal, Colorado-Wyoming Academy of Science, 34, 12-13, 2002.
- Gilliam, D. Genetic-Environmental Interactions in Susceptibility to Fetal Alcohol Effects. Presented at the annual meeting of the Research Society on Alcoholism, Fetal Alcohol Syndrome Study Group; San Francisco, CA, June 27-July 3, 2002.